Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | MRGPRX4 | Q96LA9 | 5/20 | 0.55 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | GNE | Q9Y223 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31443034 | 1.00 | KDM4E (0.61) | KDM4EALOX15TSHRACMSDTDP1 | |
| Hydrochloric Acid SCHEMBL28435938 | 0.98 | KDM4E (0.59) | KDM4EALOX15TSHRACMSDTDP1 | |
| Methyl Alcohol SCHEMBL29028982 | 0.96 | KDM4E (0.57) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL27689596 | 0.84 | CYP1A2 (0.47) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL458194 | 0.84 | MRGPRX4 (0.41) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL31591148 | 0.83 | KDM4E (0.67) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL2352264 | 0.83 | KDM4E (0.67) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL30885081 | 0.82 | NPSR1 (0.43) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL1057937 | 0.82 | NPSR1 (0.43) | KDM4EALOX15TSHRACMSDTDP1 | |
| SCHEMBL7662023 | 0.82 | KDM4E (0.64) | KDM4EALOX15TSHRACMSDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1931685-B1 | METHOD FOR OBTAINING HIGHLY LUMINESCENT LANTHANIDE COMPLEXES | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2011-08-03 | — | — | EP | claimed |
| US-20080227962-A1 | Method for Obtaining Highly Luminescent Lanthanide Complexes | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-09-18 | — | — | US | claimed |
| EP-1931685-A1 | METHOD FOR OBTAINING HIGHLY LUMINESCENT LANTHANIDE COMPLEXES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-06-18 | — | — | EP | claimed |
| WO-2007031640-A1 | METHOD FOR OBTAINING HIGHLY LUMINESCENT LANTHANIDE COMPLEXES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-03-22 | — | — | WO | claimed |
| US-12378200-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ORSOBIO, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4377321-A1 | METALLO-?-LACTAMASE INHIBITORS | University of KwaZulu-Natal (ZA) | 2024-06-05 | — | — | EP | disclosed |
| US-20240059657-A1 | OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS | OrsoBio Inc. | 2024-02-22 | — | — | US | disclosed |
| US-11780812-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ORSOBIO, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11780812-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ORSOBIO, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11780812-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ORSOBIO, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| CN-113702536-B | Detection method and application of 6-chloromethyl-2-pyridine methanol | 佛山奕安赛医药科技有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2023007325-A1 | METALLO-β-LACTAMASE INHIBITORS | UNIVERSITY OF KWAZULU-NATAL (ZA) | 2023-02-02 | — | — | WO | disclosed |
| WO-1999002501-A1 | NOVEL COMPOUNDS | ASTRA PHARMACEUTICALS LTD. (GB) | 1999-01-21 | — | — | WO | disclosed |
| US-4390543-A | Substituted pyridine methyl esters of 2-isopropyl-2-(4-chlorophenyl) acetic acid and their use as insecticides | MALHOTRA SUDARSHAN K | 1983-06-28 | — | — | US | disclosed |
| US-4262001-A | MITICIDES, PARASITICIDES, LARVICIDES | THE DOW CHEMICAL COMPANY (US) | 1981-04-14 | — | — | US | disclosed |
| US-4258048-A | Substituted pyridine methyl esters of tetramethyl cyclopropane carboxylic acids and their use as insecticides | THE DOW CHEMICAL COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
| US-4256893-A | INSECTICIDES | THE DOW CHEMICAL COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| US-4228172-A | Substituted pyridine methyl esters of 2-isopropyl-2-(4-chlorophenyl)acetic acid and their use as insecticides | THE DOW CHEMICAL COMPANY (US) | 1980-10-14 | — | — | US | disclosed |
| US-4221799-A | MITICIDES | THE DOW CHEMICAL (US) | 1980-09-09 | — | — | US | disclosed |
| US-4163787-A | Substituted pyridine methyl esters of cyclopropane carboxylic acids and their use as insecticides | THE DOW CHEMICAL COMPANY (US) | 1979-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378200-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ALDH7A1, ACMSD, AMD1 | KDM4E 1040/4885ALOX15 1451/4885TSHR 4389/4885 |
| US-20240059657-A1 | OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS | ALDH7A1, ACMSD, AMD1 | KDM4E 1040/4885ALOX15 1451/4885TSHR 4389/4885 |
| US-20080227962-A1 | Method for Obtaining Highly Luminescent Lanthanide Complexes | PYM1, C1S, C5 | KDM4E 3968/4885ALOX15 1389/4885TSHR 1220/4885 |
| US-11780812-B2 | Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors | ALDH7A1, ACMSD, AMD1 | KDM4E 1040/4885ALOX15 1451/4885TSHR 4389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.